Latest Mercury Laboratories stock price
Mercury Laboratories P/E Ratio
MERCURYLAB • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
31.25
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
31.25
Current Price
₹819.00
EPS (TTM)
₹26.21
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
57.32
Sector Median
35.38
Sector Rank
#11 of 89
Sector Percentile
12.4%
Key P/E Ratio Insights for Mercury Laboratories
- Stock appears overvalued with PE of 31.25, suggesting caution for new investments
- Trading at discount to sector average PE of 57.32
View the MERCURYLAB equity price for detailed stock performance.
Related Pages for Mercury Laboratories
Additional stock information and data for MERCURYLAB
Sector P/E Ratio Comparison
Comparing Mercury Laboratories with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |